Dignam JJ - Search Results

1

Statistical Considerations in the Evaluation of Continuous Biomarkers.

Polley MC, Dignam JJ. Polley MC, et al. Among authors: dignam jj. J Nucl Med. 2021 May 10;62(5):605-611. doi: 10.2967/jnumed.120.251520. Epub 2021 Feb 12. J Nucl Med. 2021. PMID: 33579807 Free PMC article. Review.

2

Choice and interpretation of statistical tests used when competing risks are present.

Dignam JJ, Kocherginsky MN. Dignam JJ, et al. J Clin Oncol. 2008 Aug 20;26(24):4027-34. doi: 10.1200/JCO.2007.12.9866. J Clin Oncol. 2008. PMID: 18711194 Free PMC article.

3

The use and interpretation of competing risks regression models.

Dignam JJ, Zhang Q, Kocherginsky M. Dignam JJ, et al. Clin Cancer Res. 2012 Apr 15;18(8):2301-8. doi: 10.1158/1078-0432.CCR-11-2097. Epub 2012 Jan 26. Clin Cancer Res. 2012. PMID: 22282466 Free PMC article.

4

Integrated phase II/III clinical trials in oncology: a case study.

Wang M, Dignam JJ, Zhang QE, DeGroot JF, Mehta MP, Hunsberger S. Wang M, et al. Among authors: dignam jj. Clin Trials. 2012 Dec;9(6):741-7. doi: 10.1177/1740774512464724. Epub 2012 Nov 22. Clin Trials. 2012. PMID: 23180870 Free PMC article. Review.

5

Time Interval to Biochemical Failure as a Surrogate End Point in Locally Advanced Prostate Cancer: Analysis of Randomized Trial NRG/RTOG 9202.

Dignam JJ, Hamstra DA, Lepor H, Grignon D, Brereton H, Currey A, Rosenthal S, Zeitzer KL, Venkatesan VM, Horwitz EM, Pisansky TM, Sandler HM. Dignam JJ, et al. J Clin Oncol. 2019 Jan 20;37(3):213-221. doi: 10.1200/JCO.18.00154. Epub 2018 Dec 7. J Clin Oncol. 2019. PMID: 30526194 Free PMC article. Clinical Trial.

6

Lung volume measurements as a surrogate marker for patient response in malignant pleural mesothelioma.

Labby ZE, Armato SG 3rd, Dignam JJ, Straus C, Kindler HL, Nowak AK. Labby ZE, et al. Among authors: dignam jj. J Thorac Oncol. 2013 Apr;8(4):478-86. doi: 10.1097/JTO.0b013e31828354c8. J Thorac Oncol. 2013. PMID: 23486268 Free PMC article.

7

A tissue biomarker-based model that identifies patients with a high risk of distant metastasis and differential survival by length of androgen deprivation therapy in RTOG protocol 92-02.

Pollack A, Dignam JJ, Diaz DA, Wu Q, Stoyanova R, Bae K, Dicker AP, Sandler H, Hanks GE, Feng FY. Pollack A, et al. Among authors: dignam jj. Clin Cancer Res. 2014 Dec 15;20(24):6379-88. doi: 10.1158/1078-0432.CCR-14-0075. Epub 2014 Oct 7. Clin Cancer Res. 2014. PMID: 25294917 Free PMC article.

8

Comparison of futility monitoring guidelines using completed phase III oncology trials.

Zhang Q, Freidlin B, Korn EL, Halabi S, Mandrekar S, Dignam JJ. Zhang Q, et al. Among authors: dignam jj. Clin Trials. 2017 Feb;14(1):48-58. doi: 10.1177/1740774516666502. Epub 2016 Sep 22. Clin Trials. 2017. PMID: 27590208 Free PMC article.

9

Statistical considerations in assessing molecular markers for cancer prognosis and treatment efficacy.

Dignam J, Bryant J, Paik S. Dignam J, et al. Methods Mol Biol. 2002;184:169-89. doi: 10.1385/1-59259-242-2:169. Methods Mol Biol. 2002. PMID: 11889713 Review. No abstract available.

10

Characteristics of Participation in Patient-Reported Outcomes and Electronic Data Capture Components of NRG Oncology Clinical Trials.

Pugh SL, Rodgers JP, Yeager KA, Chen RC, Movsas B, Bonanni R, Dignam J, Bruner DW. Pugh SL, et al. Int J Radiat Oncol Biol Phys. 2020 Nov 15;108(4):950-959. doi: 10.1016/j.ijrobp.2020.06.030. Epub 2020 Jun 24. Int J Radiat Oncol Biol Phys. 2020. PMID: 32590048 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

133 results

Search Page